July 29, 2020
Welcome to the Verisys Weekly Newsletter highlighting the COVID-19 regulatory updates between July 22- 28, 2020.
Verisys' Compliance Team gathers information from a variety of state and federal sources and updates our COVID-19 Resource Page daily with those updates. We have compiled the most recent updates from the past week in this email to assist your organization in serving patients during the pandemic and maintaining compliance as you bring additional providers on board to serve on the frontlines.
1135 waivers: The following state(s) submitted an additional 1135 waiver request to CMS. The approved waivers have been published by the Centers for Medicare and Medicaid Services. Unless otherwise stated, all waivers are retroactively effective March 1, 2020.
Texas (approved 07/23/2020)
• Managed care plans may be allowed two possible extensions (90 days each) to collect additional information needed to make an authorization decision that is favorable to the enrollee. During the extension period, the managed care plan will authorize and pay for the services based on the information available.
• The timeframe for enrollees to file an appeal of an adverse benefit determination is extended from 60 to 120 days.
• The timeframe for standard appeals is extended from 14 to 30 days, if the delay is in the enrollee’s interest.
Wyoming (approved 07/24/2020)
• Temporarily waive written consent required under home and community-based service programs and permit documented verbal consent as an alternate.
STATE BOARD REGULATIONS
Board of Medicine
07/20/2020: The Board extended the expiration date of temporary emergency licenses/registrations to Nov. 17, 2020. All temporary emergency licensees/registrants that wish to continue practicing in Alabama after Nov. 17 should apply now for permanent licensure/registration.
Source: Temporary emergency license
This information has been gathered from a variety of sources. Although Verisys has made every effort to provide complete, accurate and up-to-date information, Verisys makes no warranties, express or implied, or representations as to the accuracy or reliability of this information. The information is fluid and evolving. Verisys assumes no liability or responsibility for any errors or omissions in the information contained in this resource.
The information contained in this newsletter comprises all the information that we have found during those dates. It may not constitute a complete list of every regulation instituted by every board during the last week.
The Verisys Team